These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1737106)

  • 21. Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.
    Reuter CW; Krauter J; Onono FO; Bunke T; Damm F; Thol F; Wagner K; Göhring G; Schlegelberger B; Heuser M; Ganser A; Morgan MA
    Ann Hematol; 2014 Jun; 93(6):977-82. PubMed ID: 24737308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras oncogenes using the polymerase chain reaction.
    Ball ED; Mills LE; Neubauer A; Liu E
    Prog Clin Biol Res; 1990; 333():499-506. PubMed ID: 2408063
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone Marrow Clonogenic Myeloid Progenitors from
    Guardia RD; González-Silva L; López-Millán B; Rodríguez-Sevilla JJ; Baroni ML; Bueno C; Anguita E; Vives S; Palomo L; Lapillonne H; Varela I; Menendez P
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31936647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
    Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.
    Stirewalt DL; Kopecky KJ; Meshinchi S; Appelbaum FR; Slovak ML; Willman CL; Radich JP
    Blood; 2001 Jun; 97(11):3589-95. PubMed ID: 11369655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative determination of the ratio of mutated to normal ras genes in the blood of leukemia patients by allele-specific PCR.
    Horikoshi T; Lenz HJ; Danenberg K; Koch OM; Bertino JR; Danenberg PV
    Leuk Res; 1994 Sep; 18(9):693-702. PubMed ID: 7934145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
    Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-ras mutation in acute myeloid leukemia: incidence, prognostic significance and value as a marker of minimal residual disease.
    Casey G; Rudzki Z; Roberts M; Hutchins C; Juttner C
    Pathology; 1993 Jan; 25(1):57-62. PubMed ID: 8316501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-ras mutations in 43 Chinese cases of acute myeloid leukemia.
    Guo W; Tang B; Xu S; Yao Y; Ye D
    Chin Med J (Engl); 1998 Apr; 111(4):343-5. PubMed ID: 10374400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.
    Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M
    Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Detection of N-RAS Gene Common Mutations in Acute Myeloid Leukemia (AML) Using High Resolution Melting (HRM) Method.
    Zaka Khosravi S; Moonesi M; Moradabadi A; Rajaeinejad M; Heidari MF; Noroozi-Aghideh A
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):125-130. PubMed ID: 35092380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation of the p53 gene in human acute myelogenous leukemia.
    Slingerland JM; Minden MD; Benchimol S
    Blood; 1991 Apr; 77(7):1500-7. PubMed ID: 2009369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAS gene mutations in childhood acute myeloid leukemia: a Pediatric Oncology Group study.
    Vogelstein B; Civin CI; Preisinger AC; Krischer JP; Steuber P; Ravindranath Y; Weinstein H; Elfferich P; Bos J
    Genes Chromosomes Cancer; 1990 Jul; 2(2):159-62. PubMed ID: 2278970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
    Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
    Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SSCP detection of N-ras promoter mutations in AML patients.
    Thorn J; Molloy P; Iland H
    Exp Hematol; 1995 Sep; 23(10):1098-103. PubMed ID: 7656930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAS mutations in pediatric leukemias with MLL gene rearrangements.
    Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA
    Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of c-MYC oncogene and point mutation of N-RAS oncogene point mutation in acute myelocytic leukemias with double minute chromosomes.
    Tanaka K; Takechi M; Nishimura S; Oguma N; Kamada N
    Leukemia; 1993 Mar; 7(3):469-71. PubMed ID: 8445953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.
    Neubauer A; Dodge RK; George SL; Davey FR; Silver RT; Schiffer CA; Mayer RJ; Ball ED; Wurster-Hill D; Bloomfield CD
    Blood; 1994 Mar; 83(6):1603-11. PubMed ID: 8123851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.
    Lemoli RM; Fortuna A; Tafuri A; Fogli M; Amabile M; Grande A; Ricciardi MR; Petrucci MT; Bonsi L; Bagnara G; Visani G; Martinelli G; Ferrari S; Tura S
    Blood; 1996 May; 87(9):3852-9. PubMed ID: 8611712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.